General Surgery Devices are used in diagnostic and surgical interventions primarily for the gastrointestinal tract, abdomen, and pelvis. An Enteral Stent is a perforated expandable tube which is inserted into a passage of the body in order to alleviate the constriction of flow caused by any disease. GlobalData uses proprietary data and analytics to provide a comprehensive report on the enteral stents devices market, including market shares of different players within Australia. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the enteral stents market in Australia was Boston Scientific followed by Cook Medical, Taewoong Medical, MITech, Micro-Tech Nanjing and Merit Medical Systems.
Enteral Stents are primarily used to maintain patency of the lumen of the gastrointestinal tract. Enteral Stents include Non-Covered Enteral Stents, Partially Covered Enteral Stents, and Fully Covered Enteral Stents. Fully Covered Enteral Stents are covered with materials such as polytetrafluoroethylene or silicone and do not have any exposed bare metal. Non-Covered Enteral Stents have exposed bare metal with no synthetic material covering the metal mesh. Partially Covered Enteral Stents have a small portion of exposed bare metal at the proximal and distal ends.
The value of the enteral stents devices market within Australia was expected to be over $4m in 2023.
For the latest complete market share analysis of enteral stents device market in Australia, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
